Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

By sjmartinez • October 30, 2023

Cheema HA, Shafiee A, Athar MMT, Rafiei MA, Mehmannavaz A, Jafarabady K, Shahid A, Ahmad A, Ijaz SH, Dani SS, Minhas AMK, Nashwan AJ, Fudim M, Fonarow GC. Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2023 Oct 12;10:1273781. doi: 10.3389/fcvm.2023.1273781. PMID: 37900570; PMCID: PMC10602781.

Tags: Cardiology/Epi, dapagliflozin, empagliflozin, heart failure, HFPEF, Publications, SGLT2I

The Vestigial Fold in Humans: Characterization of a Potential Novel Target for Selective Cardiac Sympathetic Denervation

Sato T, Fishbein MC, Hanna P, Ajijola OA, Shivkumar K, Mori S. The Vestigial Fold in Humans: Characterization of a Potential Novel Target for Selective[...]

Atherogenic Effects of Acute Electronic Cigarette Compared With Tobacco Cigarette Smoking in People Living With HIV: A Randomized Crossover Trial

Kelesidis T, Fotooh Abadi L, Ruedisueli I, D'Costa ZU, Middlekauff HR. Atherogenic Effects of Acute Electronic Cigarette Compared With Tobacco Cigarette Smoking in People Living[...]

Multicenter study of heart failure phenotypes and physician-adjudicated etiologies in people with HIV

Beydoun N, Nance RM, Durstenfeld MS, Hoffmann AP, Whitney BM, Burkholder GA, Health S, Hsue PY, Saag M, Delaney JA, Longenecker CT, Crane HM, Feinstein[...]